Health care startups that raised Series A
Source: FundingWatcher. Data as of 4 September 2026.
5,277
Companies
$70.6B
Last round total
100
Rows shown
4 September 2026
Data as of
Latest rounds
Most recent round first
100 rows
| # | Company | Round | Amount | Date | City | Sector |
|---|---|---|---|---|---|---|
| 1 | Xianyan Biopharma | Series A | $21.8M | 2026-08-31 | Chengdu | Biotech |
| 2 | ABLE Labs | Series A | $8.8M | 2026-08-31 | Incheon | Biotech |
| 3 | Digicuto | Series A | $17.4M | 2026-08-28 | Marseille | Artificial intelligence |
| 4 | Selio Medical | Series A | $5.8M | 2026-08-28 | Dublin | Health care |
| 5 | Hepo Biotechnology | Series A | 2026-08-28 | Shanghai | Biotech | |
| 6 | Metriport | Series A | $26.0M | 2026-08-27 | San Francisco | Health care |
| 7 | InstaAstro | Series A | $12.0M | 2026-08-27 | Noida | Health care |
| 8 | Onos Health | Series A | $17.0M | 2026-08-26 | San Francisco | Artificial intelligence |
| 9 | Hike Medical | Series A | $22.5M | 2026-08-25 | San Francisco | Artificial intelligence |
| 10 | TECLens | Series A | $10.0M | 2026-08-25 | Stamford | Health care |
| 11 | Anda Biopharma | Series A | 2026-08-24 | Shenzhen | Artificial intelligence | |
| 12 | SiranBio | Series A | $59.5M | 2026-08-20 | Suzhou | Biotech |
| 13 | MaxQ Medical | Series A | $20.0M | 2026-08-20 | Sunnyvale | Health care |
| 14 | Buddy Bites | Series A | $4.2M | 2026-08-20 | Sheung Wan | Health care |
| 15 | Kynexis | Series A | $112.3M | 2026-08-19 | Naarden | Biotech |
| 16 | KaliVir Immunotherapeutics | Series A | $14.0M | 2026-08-19 | Pittsburgh | Health care |
| 17 | Happy Health | Series A | $75.0M | 2026-08-18 | Austin | Health care |
| 18 | Lissun | Series A | $5.0M | 2026-08-18 | Gurgaon | Health care |
| 19 | Leal Therapeutics | Series A | $30.0M | 2026-08-17 | Worcester | Health care |
| 20 | Enginprime Medical | Series A | $12.0M | 2026-08-17 | Shanghai | Biotech |
| 21 | BiPSEE | Series A | 2026-08-17 | Tokyo | Hardware | |
| 22 | Aligned Marketplace | Series A | $20.0M | 2026-08-13 | New York | Commerce |
| 23 | Errui Xinyue | Series A | $14.3M | 2026-08-13 | Daxing | Biotech |
| 24 | Remepy | Series A | $36.0M | 2026-08-12 | Ramat Gan | Biotech |
| 25 | Teal Health | Series A | $18.3M | 2026-08-12 | San Francisco | Health care |
| 26 | Paterna Biosciences | Series A | $6.3M | 2026-08-12 | Salt Lake City | Biotech |
| 27 | Infinimmune | Series A | $75.0M | 2026-08-11 | Alameda | Artificial intelligence |
| 28 | Bunker Kids | Series A | $10.6M | 2026-08-11 | Busan | Health care |
| 29 | Omega Ophthalmics | Series A | $7.0M | 2026-08-11 | Lexington | Biotech |
| 30 | West Lake Xinchen | Series A | $14.8M | 2026-08-10 | Hangzhou | Artificial intelligence |
| 31 | Remedium Bio | Series A | $10.0M | 2026-08-10 | Needham | Biotech |
| 32 | ClonOrgan | Series A | 2026-08-07 | Chengdu | Biotech | |
| 33 | Ommo Technologies | Series A | 2026-08-07 | Carrollton | Hardware | |
| 34 | Mingche Technology | Series A | 2026-08-06 | Suzhou | Health care | |
| 35 | Phil Rivers Technology | Series A | $29.6M | 2026-08-05 | Beijing | Artificial intelligence |
| 36 | Blend | Series A | $12.0M | 2026-08-05 | Columbus | Health care |
| 37 | Salus Scientific | Series A | $10.1M | 2026-08-05 | Mount Pleasant | Health care |
| 38 | Andromeda Surgical | Series A | $15.0M | 2026-08-04 | San Francisco | Artificial intelligence |
| 39 | Mingzhun Medical | Series A | $1.4M | 2026-08-04 | Longhua | Health care |
| 40 | Dash Bio | Series A | $30.0M | 2026-08-03 | Boston | Artificial intelligence |
| 41 | Algen Biotechnologies | Series A | $12.5M | 2026-08-03 | San Francisco | Artificial intelligence |
| 42 | NovOrientIT | Series A | $470K | 2026-07-31 | Astana | Artificial intelligence |
| 43 | Beyond Therapeutics | Series A | $29.6M | 2026-07-30 | Shanghai | Biotech |
| 44 | STMed Technology | Series A | $29.6M | 2026-07-30 | Suzhou | Health care |
| 45 | Yuantian Bio | Series A | $14.8M | 2026-07-30 | Tianjin | Biotech |
| 46 | Genta Kyushu Bio | Series A | $14.8M | 2026-07-30 | Beijing | Biotech |
| 47 | Sound Health | Series A | $12.2M | 2026-07-30 | San Francisco | Health care |
| 48 | Trace Biosciences | Series A | $8.3M | 2026-07-29 | Beaverton | Biotech |
| 49 | CORE Biomedicine | Series A | $21.0M | 2026-07-28 | Allston | Biotech |
| 50 | Sound Health & Wellness Center | Series A | $12.2M | 2026-07-28 | Bothell | Health care |
| 51 | Throne | Series A | $10.0M | 2026-07-28 | Austin | Health care |
| 52 | Procode AI | Series A | $10.0M | 2026-07-28 | Los Angeles | Artificial intelligence |
| 53 | GOLGENIA | Series A | $1.7M | 2026-07-28 | Milano | Biotech |
| 54 | Flourish Health | Series A | $26.0M | 2026-07-27 | Richmond | Health care |
| 55 | Valendo Health | Series A | $14.5M | 2026-07-26 | New York | Health care |
| 56 | Tonglu Technology | Series A | 2026-07-26 | Shenzhen | Health care | |
| 57 | Magnendo | Series A | $18.0M | 2026-07-24 | Newton | Artificial intelligence |
| 58 | Elio Labs | Series A | $21.0M | 2026-07-23 | San Mateo | Artificial intelligence |
| 59 | CARPL.ai | Series A | $10.0M | 2026-07-23 | San Francisco | Artificial intelligence |
| 60 | Cooler Heads | Series A | $3.3M | 2026-07-23 | San Diego | Biotech |
| 61 | Transcripta Bio | Series A | $24.0M | 2026-07-22 | Palo Alto | Biotech |
| 62 | Assured Health | Series A | $19.0M | 2026-07-22 | Irving | Artificial intelligence |
| 63 | Tikva Allocell | Series A | $8.0M | 2026-07-22 | Singapore | Biotech |
| 64 | TYBR Health | Series A | $30.0M | 2026-07-21 | Houston | Health care |
| 65 | N-Zyme Biomedical | Series A | $4.6M | 2026-07-21 | Milwaukee | Biotech |
| 66 | Fibrox | Series A | $3.7M | 2026-07-21 | Pudong | Biotech |
| 67 | Red Bear AI | Series A | $30.5M | 2026-07-20 | Xuhui | Artificial intelligence |
| 68 | Karoo Health | Series A | $16.2M | 2026-07-20 | Albuquerque | Health care |
| 69 | Plazza | Series A | $15.0M | 2026-07-20 | Bangalore | Commerce |
| 70 | Brenus Pharma | Series A | $12.6M | 2026-07-20 | Issoire | Biotech |
| 71 | Radial | Series A | $3.0M | 2026-07-20 | New York | Health care |
| 72 | Clarity Care AI | Series A | $3.5M | 2026-07-17 | Dover | Artificial intelligence |
| 73 | Ascléa | Series A | 2026-07-15 | Berlin | Artificial intelligence | |
| 74 | DeyeeMed | Series A | 2026-07-15 | Baoan | Artificial intelligence | |
| 75 | Bay Imaging | Series A | 2026-07-14 | Shenzhen | Health care | |
| 76 | Tianhu Technology | Series A | $29.0M | 2026-07-13 | Minhang | Artificial intelligence |
| 77 | Corner Health | Series A | $25.0M | 2026-07-13 | Santa Monica | Artificial intelligence |
| 78 | MingCeler | Series A | 2026-07-13 | Guangzhou | Biotech | |
| 79 | Shenzhen Bay Island Cell Technology | Series A | $20.6M | 2026-07-10 | Biotech | |
| 80 | Alchemab Therapeutics | Series A | $33.6M | 2026-07-09 | London | Biotech |
| 81 | CurifyLabs | Series A | $13.7M | 2026-07-06 | Helsinki | Health care |
| 82 | Insaifeiying | Series A | 2026-07-06 | Suzhou | Biotech | |
| 83 | Telum Therapeutics | Series A | $20.5M | 2026-07-01 | Noáin | Biotech |
| 84 | Integral Privacy Technologies | Series A | $18.0M | 2026-07-01 | San Francisco | Artificial intelligence |
| 85 | InStockRx | Series A | $5.0M | 2026-07-01 | Boston | Commerce |
| 86 | Life365 | Series A | $4.5M | 2026-07-01 | Scottsdale | Artificial intelligence |
| 87 | Beeline Medicines | Series A | $126.3M | 2026-06-30 | Boston | Biotech |
| 88 | Xellar Biosystems | Series A | $29.5M | 2026-06-30 | Newton | Artificial intelligence |
| 89 | Ognomy Sleep | Series A | $20.0M | 2026-06-30 | Buffalo | Health care |
| 90 | Prime Lifescience | Series A | $14.7M | 2026-06-30 | Hangzhou | Biotech |
| 91 | Apothékary | Series A | $10.0M | 2026-06-29 | Falls Church | Commerce |
| 92 | Mykare Health | Series A | $1.0M | 2026-06-29 | Ernakulam | Health care |
| 93 | Lingtai Krypton Biotechnology | Series A | $13.7M | 2026-06-26 | Shuangliu | Biotech |
| 94 | Hera | Series A | $27.0M | 2026-06-25 | New York | Health care |
| 95 | Upside | Series A | $20.0M | 2026-06-25 | Fort Lauderdale | Health care |
| 96 | Tombot | Series A | $7.0M | 2026-06-25 | Santa Clarita | Hardware |
| 97 | SuperLiving | Series A | $7.0M | 2026-06-25 | Bengaluru | Health care |
| 98 | RQ Bio | Series A | $112.5M | 2026-06-24 | London | Biotech |
| 99 | Runlayer | Series A | $30.0M | 2026-06-24 | New York | Artificial intelligence |
| 100 | Anodyne Nanotech | Series A | $12.6M | 2026-06-24 | Boston | Biotech |
Table 1. The 100 most recent rounds. Source: FundingWatcher. Data as of 4 September 2026. Base: 5,277.
Largest rounds
Largest round first
100 rows
| # | Company | Round | Amount | Date | City | Sector |
|---|---|---|---|---|---|---|
| 1 | Altos Labs | Series A | $3.0B | 2021-09-06 | San Francisco | Biotech |
| 2 | Ping An Healthcare Management | Series A | $1.1B | 2018-02-03 | Shanghai | Fintech |
| 3 | Xaira Therapeutics | Series A | $1.0B | 2024-04-23 | South San Francisco | Artificial intelligence |
| 4 | United Imaging Healthcare | Series A | $503.5M | 2017-09-15 | Shanghai | Health care |
| 5 | Verdiva Bio | Series A | $411.0M | 2025-01-09 | London | Biotech |
| 6 | LianBio | Series A | $310.0M | 2020-10-29 | Shanghai | Biotech |
| 7 | Uniquity Bio | Series A | $300.0M | 2024-05-15 | Malvern | Biotech |
| 8 | ReNAgade Therapeutics | Series A | $300.0M | 2023-05-23 | Cambridge | Biotech |
| 9 | Mabwell Biotech | Series A | $278.5M | 2020-04-29 | Shanghai | Biotech |
| 10 | Orbital Therapeutics | Series A | $270.0M | 2023-04-26 | Cambridge | Biotech |
| 11 | NantOmics | Series A | $250.8M | 2015-06-01 | Culver City | Biotech |
| 12 | Anthos Therapeutics | Series A | $250.0M | 2019-02-27 | Cambridge | Biotech |
| 13 | Aiolos Bio | Series A | $245.0M | 2023-10-24 | San Francisco | Biotech |
| 14 | BlueRock Therapeutics | Series A | $225.0M | 2016-12-12 | Toronto | Biotech |
| 15 | Dispatch Bio | Series A | $216.0M | 2025-07-23 | Philadelphia | Biotech |
| 16 | Tome Biosciences | Series A | $213.0M | 2023-12-12 | Watertown | Biotech |
| 17 | AirNexis Therapeutics | Series A | $200.0M | 2026-01-09 | Palo Alto | Biotech |
| 18 | Treeline Biosciences | Series A | $200.0M | 2025-09-03 | Watertown | Biotech |
| 19 | Tenvie Therapeutics | Series A | $200.0M | 2025-01-08 | South San Francisco | Biotech |
| 20 | Soufflé Therapeutics | Series A | $200.0M | 2025-01-01 | Watertown | Biotech |
| 21 | Callio Therapeutics | Series A | $187.0M | 2025-03-03 | Seattle | Biotech |
| 22 | Braveheart Bio | Series A | $185.0M | 2025-11-05 | San Francisco | Biotech |
| 23 | cAMPfield Therapeutics | Series A | $180.0M | 2026-05-20 | San Diego | Biotech |
| 24 | Timberlyne Therapeutics | Series A | $180.0M | 2025-01-09 | San Diego | Biotech |
| 25 | Antares Therapeutics | Series A | $177.0M | 2025-05-15 | Boston | Biotech |
| 26 | Allist Pharmaceuticals | Series A | $173.9M | 2019-05-24 | Shanghai | Biotech |
| 27 | SPH KYUAN | Series A | $173.9M | 2015-08-18 | Fengtai | Health care |
| 28 | Syremis Therapeutics | Series A | $165.0M | 2025-12-18 | Tel Aviv | Health care |
| 29 | Wego | Series A | $155.0M | 2021-10-29 | Nanshan | Health care |
| 30 | Korsana Biosciences | Series A | $150.0M | 2025-09-01 | Waltham | Biotech |
| 31 | Clasp Therapeutics | Series A | $150.0M | 2024-03-20 | Cambridge | Biotech |
| 32 | Curon Biopharma | Series A | $150.0M | 2018-07-30 | Shanghai | Biotech |
| 33 | Bitterroot Bio | Series A | $145.0M | 2023-06-07 | Palo Alto | Biotech |
| 34 | Doma Biopharmaceutical | Series A | $142.1M | 2022-06-01 | Suzhou | Biotech |
| 35 | Ottimo Pharma | Series A | $140.0M | 2024-12-19 | Sandwich | Biotech |
| 36 | United Imaging Intelligence | Series A | $139.3M | 2025-06-20 | Xuhui | Health care |
| 37 | VectorY | Series A | $138.0M | 2023-11-13 | Amsterdam | Biotech |
| 38 | Serapha Bio | Series A | $138.0M | 2026-01-01 | New York | Biotech |
| 39 | EverBridge | Series A | $137.8M | 2025-03-25 | Changning | Health care |
| 40 | EasyHealth | Series A | $135.0M | 2021-11-18 | Los Angeles | Fintech |
| 41 | Reunion Neuroscience | Series A | $133.0M | 2025-09-16 | Toronto | Biotech |
| 42 | Slate Medicines | Series A | $130.0M | 2026-02-24 | Raleigh | Biotech |
| 43 | Beeline Medicines | Series A | $126.3M | 2026-06-30 | Boston | Biotech |
| 44 | Coultreon Biopharma | Series A | $125.0M | 2026-04-28 | Heverlee | Biotech |
| 45 | Ambros Therapeutics | Series A | $125.0M | 2025-12-16 | Irvine | Biotech |
| 46 | Adcytherix | Series A | $122.8M | 2025-10-16 | Marseille | Biotech |
| 47 | NGM Biopharmaceuticals | Series A | $122.0M | 2024-07-17 | South San Francisco | Biotech |
| 48 | Merida Biosciences | Series A | $121.0M | 2025-04-08 | Cambridge | Biotech |
| 49 | Solve Therapeutics | Series A | $120.0M | 2025-11-17 | Belmont | Biotech |
| 50 | Ouro Medicines | Series A | $120.0M | 2025-01-10 | San Francisco | Biotech |
| 51 | Cellular Biomedicine Group | Series A | $120.0M | 2021-09-28 | Palo Alto | Biotech |
| 52 | Myricx Bio | Series A | $115.3M | 2024-07-08 | London | Biotech |
| 53 | Axonis Therapeutics | Series A | $115.0M | 2024-10-30 | Boston | Biotech |
| 54 | Author Health | Series A | $115.0M | 2023-06-28 | Boston | Health care |
| 55 | RQ Bio | Series A | $112.5M | 2026-06-24 | London | Biotech |
| 56 | Kynexis | Series A | $112.3M | 2026-08-19 | Naarden | Biotech |
| 57 | Syncromune | Series A | $111.8M | 2024-12-20 | Fort Lauderdale | Biotech |
| 58 | Zephyr AI | Series A | $111.0M | 2024-03-13 | Fairfax Station | Artificial intelligence |
| 59 | PanTera | Series A | $110.3M | 2024-09-11 | Mol | Health care |
| 60 | Zarminali Health | Series A | $110.0M | 2026-01-21 | Chicago | Health care |
| 61 | RayThera | Series A | $110.0M | 2025-04-04 | San Diego | Biotech |
| 62 | Neogene Therapeutics | Series A | $110.0M | 2020-09-14 | Amsterdam | Biotech |
| 63 | Sidera Bio | Series A | $109.0M | 2025-12-09 | Copenhagen | Biotech |
| 64 | AavantiBio | Series A | $107.0M | 2020-10-22 | Cambridge | Biotech |
| 65 | Synnovation Therapeutics | Series A | $102.0M | 2023-12-14 | Wilmington | Biotech |
| 66 | NILO Therapeutics | Series A | $101.0M | 2025-10-08 | New York | Biotech |
| 67 | Trace Neuroscience | Series A | $101.0M | 2024-11-12 | South San Francisco | Biotech |
| 68 | Stipple Bio | Series A | $100.0M | 2026-04-06 | Cambridge | Biotech |
| 69 | Addition Therapeutics | Series A | $100.0M | 2025-12-17 | South San Francisco | Biotech |
| 70 | Nudge | Series A | $100.0M | 2025-07-22 | San Francisco | Biotech |
| 71 | C Ray Therapeutics | Series A | $100.0M | 2024-11-16 | Chengdu | Health care |
| 72 | Lumeris | Series A | $100.0M | 2024-04-10 | St Louis | Health care |
| 73 | OnCusp Therapeutics | Series A | $100.0M | 2024-01-04 | New York | Biotech |
| 74 | Inceptive | Series A | $100.0M | 2023-09-07 | Palo Alto | Biotech |
| 75 | Paratus Sciences | Series A | $100.0M | 2023-02-27 | New York | Biotech |
| 76 | Allied Health Clinics | Series A | $100.0M | 2022-07-04 | Cape Town | Health care |
| 77 | Reistone Biopharma | Series A | $100.0M | 2022-05-09 | Pudong | Biotech |
| 78 | Tichuang Biotechnology | Series A | $100.0M | 2022-03-14 | Guangzhou | Biotech |
| 79 | Rectify Pharmaceuticals | Series A | $100.0M | 2021-10-14 | Cambridge | Biotech |
| 80 | Dyno Therapeutics | Series A | $100.0M | 2021-05-06 | Cambridge | Artificial intelligence |
| 81 | Joyn Bio | Series A | $100.0M | 2017-09-14 | Boston | Biotech |
| 82 | Emergence Therapeutics | Series A | $98.1M | 2021-12-07 | Duisburg | Biotech |
| 83 | NanoPhoria | Series A | $97.8M | 2025-10-06 | Milan | Biotech |
| 84 | Cajal Neuroscience | Series A | $96.0M | 2022-11-29 | Seattle | Biotech |
| 85 | Trogenix | Series A | $94.1M | 2025-10-06 | Edinburgh | Biotech |
| 86 | Firefly Bio | Series A | $94.0M | 2024-02-15 | San Francisco | Biotech |
| 87 | Orbis Medicines | Series A | $93.5M | 2025-01-06 | Frederiksberg | Health care |
| 88 | Memento Medicines | Series A | $93.0M | 2026-06-18 | Chester | Biotech |
| 89 | Kivu Bioscience | Series A | $92.0M | 2024-10-28 | San Francisco | Biotech |
| 90 | Bambusa Therapeutics | Series A | $90.0M | 2025-11-17 | Boston | Biotech |
| 91 | AtomVie Global Radiopharma | Series A | $90.0M | 2023-06-01 | Hamilton | Health care |
| 92 | Nested Therapeutics | Series A | $90.0M | 2022-10-06 | Cambridge | Biotech |
| 93 | Turing Pharmaceuticals | Series A | $90.0M | 2015-08-10 | New York | Biotech |
| 94 | Clade Therapeutics | Series A | $87.0M | 2021-11-03 | Cambridge | Biotech |
| 95 | MoleculeMind | Series A | $86.0M | 2026-06-17 | Haidian | Artificial intelligence |
| 96 | Rhygaze | Series A | $86.0M | 2025-01-10 | Basel | Biotech |
| 97 | Stylus Medicine | Series A | $85.0M | 2025-05-12 | Cambridge | Biotech |
| 98 | Rampart Bioscience | Series A | $85.0M | 2023-10-24 | La Jolla | Biotech |
| 99 | Epirium Bio | Series A | $85.0M | 2019-12-18 | San Diego | Biotech |
| 100 | Averna Therapeutics | Series A | $85.0M | 2024-06-25 | Boston | Biotech |
Table 2. The 100 largest rounds. Source: FundingWatcher. Data as of 4 September 2026. Base: 5,277.
By month
| Month | Companies |
|---|---|
| 2024-09 | 36 |
| 2024-10 | 50 |
| 2024-11 | 51 |
| 2024-12 | 55 |
| 2025-01 | 72 |
| 2025-02 | 36 |
| 2025-03 | 46 |
| 2025-04 | 49 |
| 2025-05 | 48 |
| 2025-06 | 56 |
| 2025-07 | 50 |
| 2025-08 | 56 |
| 2025-09 | 76 |
| 2025-10 | 61 |
| 2025-11 | 56 |
| 2025-12 | 74 |
| 2026-01 | 76 |
| 2026-02 | 51 |
| 2026-03 | 58 |
| 2026-04 | 45 |
| 2026-05 | 41 |
| 2026-06 | 65 |
| 2026-07 | 45 |
| 2026-08 | 41 |
Table 3. Health care startups that raised Series A by month of the round. Source: FundingWatcher. Data as of 4 September 2026. Base: 5,277.
Country
| Country | Companies |
|---|---|
| United States | 2,237 |
| China | 1,178 |
| United Kingdom | 224 |
| South Korea | 199 |
| India | 144 |
| Germany | 129 |
| France | 128 |
| Canada | 103 |
| Japan | 96 |
| Switzerland | 91 |
| Israel | 88 |
| Australia | 49 |
| The Netherlands | 45 |
| Singapore | 45 |
| Spain | 43 |
Table 4. Health care startups that raised Series A by country. Source: FundingWatcher. Data as of 4 September 2026. Base: 5,277.
City
| City | Companies |
|---|---|
| New York | 223 |
| San Francisco | 204 |
| Beijing | 164 |
| Shanghai | 154 |
| Shenzhen | 110 |
| London | 107 |
| Cambridge | 106 |
| Hangzhou | 97 |
| Boston | 93 |
| Seoul | 85 |
| Suzhou | 72 |
| San Diego | 69 |
| Paris | 55 |
| Los Angeles | 54 |
| Palo Alto | 50 |
Table 5. Health care startups that raised Series A by city. Source: FundingWatcher. Data as of 4 September 2026. Base: 5,277.
Sector
| Sector | Companies |
|---|---|
| Health care | 5,277 |
| Biotech | 1,914 |
| Software | 1,117 |
| Artificial intelligence | 500 |
| Hardware | 322 |
| Commerce | 198 |
| Fintech | 186 |
| Education | 84 |
| Energy | 26 |
| Cybersecurity | 18 |
Table 6. Health care startups that raised Series A by sector. Source: FundingWatcher. Data as of 4 September 2026. Base: 5,277.
Health care at other stages
Other sectors that raised Series A
software startups that raised Series A13,389
AI startups that raised Series A4,006
fintech startups that raised Series A3,577
commerce startups that raised Series A3,637
hardware startups that raised Series A4,426
biotech startups that raised Series A2,362
education startups that raised Series A1,275
cybersecurity startups that raised Series A1,149
energy startups that raised Series A1,021
Cite: FundingWatcher, 5,277 health care companies whose most recent round is Series A, 4 September 2026. https://fundingwatcher.com/startups/health-care/series-a/